Genome sequencing: patients may consent without understanding
Qualitative study finds patients with cancer wrestle with decision-making on testing
Many patients planning to undergo genome sequencing to learn about the genetic variants that may have predisposed them to cancer do not fully understand what genetic testing is, Australian researchers say.
Despite their poor knowledge, all 20 participants in a qualitative study had consented to the testing and provided blood samples, they said.
